ID
23139
Beskrivning
Responsible Party: Teva Pharma GmbH ClinicalTrials.gov Identifier: NCT02384577 History of Changes Other Study ID Numbers: BFS-AS-40074 DRKS00006542 ( Registry Identifier: German Clinical Trials Register ) Study First Received: March 4, 2015 Last Updated: November 3, 2016 Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02384577
Länk
https://clinicaltrials.gov/ct2/show/NCT02384577
Nyckelord
Versioner (1)
- 2017-06-25 2017-06-25 -
Uppladdad den
25 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Asthma and COPD Treatment DRKS00006542 NCT02384577 DRKS00006542
Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542
- StudyEvent: ODM
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beskrivning
Contraindication
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1301624
Beskrivning
Study Participation Status
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Beskrivning
Comorbidity
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0009488
Beskrivning
Substance Use Disorder
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2702800
Beskrivning
Language Ability
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1145677
Beskrivning
Study planning
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0681871
Beskrivning
Incapable of giving informed consent
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1550518
Similar models
Eligibility Asthma and COPD Treatment NCT02384577 DRKS00006542
- StudyEvent: ODM
C0024117 (UMLS CUI [2])
C0001644 (UMLS CUI [2,1])
C0205166 (UMLS CUI [2,2])
C1550518 (UMLS CUI [1,2])